Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments/Experiment 1/Signature 2
From BugSigDB
< Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments | Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments/Experiment 1(Redirected from Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments/Experiment 1/Signature 2)
Reviewed Marked as Reviewed by Svetlana up on 2024-12-24
Source: Figure 7A
Description: Differential abundance of significantly different bacterial taxa Between Before CDI (Clostridioides difficile infection) and Survived mice.
Abundance in Group 1: decreased abundance in Survived mice
